Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)

China flag China · Delayed Price · Currency is CNY
58.65
+1.38 (2.41%)
Sep 5, 2025, 3:04 PM CST
2.41%
Market Cap65.06B
Revenue (ttm)4.04B
Net Income (ttm)359.56M
Shares Out1.11B
EPS (ttm)0.32
PE Ratio182.29
Forward PE123.91
Dividend0.42 (0.71%)
Ex-Dividend DateMay 15, 2025
Volume4,658,785
Average Volume5,162,218
Open55.48
Previous Close57.27
Day's Range55.48 - 58.67
52-Week Range29.13 - 62.65
Beta-0.13
RSI58.51
Earnings DateAug 23, 2025

About SHE:002653

Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products in China. The company offers anesthetic analgesic, neuropsychiatric system, and digestive liver and parenteral nutrition medications; drugs for the endocrine and cardiovascular system; oncology-related drugs; andrology drugs; desonide and liprocaine cream; propofol medium/long chain fat emulsion and hydroxyethyl starch sodium chloride injection; sodium fusidicate ointment; lupatadine fumarate tablets; and caspofungin acetate and methylpre... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 5,337
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002653
Full Company Profile

Financial Performance

In 2024, SHE:002653's revenue was 3.72 billion, an increase of 10.92% compared to the previous year's 3.36 billion. Earnings were 395.46 million, an increase of 34.00%.

Financial Statements

News

There is no news available yet.